Elevate your peptide aggregation knowledge with experts. Get analytical expertise on peptide aggregation and how to avoid it through optimized downstream process conditions in our on-demand webinar in partnership with Bachem. Topics covered include: • The fundamentals of aggregation behaviors • Techniques to monitor and measure peptide aggregates • How to get an operating window to mitigate the risk of aggregation Complete the form to watch the on-demand webinar: https://ow.ly/BqmH50Qaajz. #PeptideAggregation #DrugDevelopment #PharmaIgnite
Citeline Clinical’s Post
More Relevant Posts
-
Understanding the oligomerization and aggregation potential of peptide candidates is key to developing long-acting and stable drugs. In this on-demand webinar in partnership with Bachem, you will learn more about: • The fundamentals of aggregation behaviors • Techniques to monitor and measure peptide aggregates • How to get an operating window to mitigate risk of aggregation Complete the form to watch the on-demand webinar: https://ow.ly/EKuq50QkMHW. #PeptideAggregation #DrugDevelopment #PharmaIgnite
Webinar: Why Robust Analytical Testing Is Critical in Drug Development
discover.pharmaignite.com
To view or add a comment, sign in
-
Last chance to register for our Nitrosamines in Focus webinar! Nitrosamines, potent carcinogens, are now under the regulatory microscope. Are you equipped to navigate the complex landscape of detection, control, and compliance? Join our webinar on Sept. 12, 2024 at 10:00am ET to learn how to: ✅ Understand the regulatory requirements and guidelines ✅ Implement robust analytical methods ✅ Mitigate risks in your production process ✅ Benefit from real-world case studies Register here ➡️ https://hubs.li/Q02PyRPn0 #Nitrosamines #CarcinogenControl #PharmaceuticalRegulations #MedicalDevices #RiskAssessment #AnalyticalMethods #ComplianceStrategies #RegulatoryRequirements #LabBestPractices #HighRisk #Webinar #PharmaCompliance #ProductSafety #AnalyticalChemistry
To view or add a comment, sign in
-
-
Peptide Synthesis Market worth $859 million by 2028 Download PDF Brochure@ https://lnkd.in/dSgbb2By The report "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028", is projected to USD 859 million by 2028 from USD 601 million in 2023, at a CAGR of 7.4% between 2023 and 2028. Growth in this market is driven by the increasing demand for #peptide, technological advancements in #peptidesynthesis and expanding #therapeutic applications. Furthermore, rising investment in #research and #development, and a supportive market ecosystem, use of #peptides in #pharmaceuticaldrugs are some of major elements anticipated spur the market growth. However, the lack of a unified set of regulations for #therapeuticpeptides and the high cost of instruments are expected to restrain the growth of this market during the forecast period. Companies Profiled in This Report: Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland). Other Companies Operating in This Industry, Globally: PolyPeptide Group JPT Peptide Technologies AAPPTec ChinaPeptides Co., Ltd. AstraZeneca Bio Synthesis Synlogic Labcorp Nitto Denko Corporation SYNTHELIS Mimotopes ABZENA PLC Pion Inc. MedChemExpress LLC Biosynthema, Inc. Bio-Rad Laboratories BioLegend AmbioPharm - A Global Peptide CDMO Zymeworks Inc. Ginkgo Bioworks, Inc. Protagen Protein Services GmbH Celgene Aldevron Iris Biotech GmbH EpiCypher, Inc.
Peptide Synthesis Market
marketsandmarkets.com
To view or add a comment, sign in
-
Navigating the limitations of traditional identification methods is critical in developing a solid contamination control strategy. This comprehensive seminar offers an in-depth analysis of MALDI-TOF technology, showcasing its alignment with regulatory compliance and its advantages over other sequencing methodologies. Access this seminar to learn more about the essential role of MALDI-TOF technology for efficient microbial identification: https://okt.to/IH9XkD
Exploring MALDI-TOF Mass Spectrometry for Microbiology
criver.com
To view or add a comment, sign in
-
𝐏𝐞𝐩𝐭𝐢𝐝𝐞 𝐒𝐲𝐧𝐭𝐡𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐰𝐨𝐫𝐭𝐡 $859 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 2028 Download PDF Brochure for More Details@ https://lnkd.in/d9FbDguu The report "𝑷𝒆𝒑𝒕𝒊𝒅𝒆 𝑺𝒚𝒏𝒕𝒉𝒆𝒔𝒊𝒔 𝑴𝒂𝒓𝒌𝒆𝒕 𝒃𝒚 𝑹𝒆𝒂𝒈𝒆𝒏𝒕𝒔 (𝑹𝒆𝒔𝒊𝒏𝒔, 𝑨𝒎𝒊𝒏𝒐 𝑨𝒄𝒊𝒅, 𝑫𝒚𝒆𝒔), 𝑬𝒒𝒖𝒊𝒑𝒎𝒆𝒏𝒕 (𝑷𝒆𝒑𝒕𝒊𝒅𝒆 𝑺𝒚𝒏𝒕𝒉𝒆𝒔𝒊𝒛𝒆𝒓, 𝑪𝒉𝒓𝒐𝒎𝒂𝒕𝒐𝒈𝒓𝒂𝒑𝒉𝒚, 𝑳𝒚𝒐𝒑𝒉𝒊𝒍𝒊𝒛𝒆𝒓), 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚 (𝑺𝒐𝒍𝒊𝒅-𝒑𝒉𝒂𝒔𝒆, 𝑺𝒐𝒍𝒖𝒕𝒊𝒐𝒏-𝒑𝒉𝒂𝒔𝒆, 𝑯𝒚𝒃𝒓𝒊𝒅), 𝑺𝒆𝒓𝒗𝒊𝒄𝒆𝒔, 𝑬𝒏𝒅 𝑼𝒔𝒆𝒓 (𝑷𝒉𝒂𝒓𝒎𝒂, 𝑩𝒊𝒐𝒕𝒆𝒄𝒉, 𝑪𝑹𝑶), 𝑹𝒆𝒈𝒊𝒐𝒏 - 𝑮𝒍𝒐𝒃𝒂𝒍 𝑭𝒐𝒓𝒆𝒄𝒂𝒔𝒕 𝒕𝒐 2028", is projected to USD 859 million by 2028 from USD 601 million in 2023, at a CAGR of 7.4% between 2023 and 2028. Growth in this market is driven by the increasing demand for #peptide, technological advancements in #peptidesynthesis and expanding #therapeutic applications. Furthermore, rising investment in research and development, and a supportive market ecosystem, use of peptides in #pharmaceuticaldrugs are some of major elements anticipated spur the market growth. Key Players operating in This Market: Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany GenScript Bachem Kaneka North America Biotage Syngene International Limited Mesa Laboratories, Inc. CEM Corporation ProteoGenix Bio Synthesis Dalton Pharma Services AAPPTec AnyGenes® CSBio Advanced ChemTech Luxembourg Bio Technologies Ltd. JPT Peptide Technologies AmbioPharm - A Global Peptide CDMO Aurigene Pharmaceutical Services Limited Corden Pharma - A Full-Service CDMO CPC Scientific Inc. Purolite, An Ecolab Company. #PeptideSynthesisMarket #MarketGrowth #HealthcareInnovation #BiotechIndustry #PharmaceuticalResearch #PeptideTherapeutics #DrugDevelopment #MedicalResearch #SyntheticBiology #Biotechnology #PeptideProduction #MarketForecast #LifeSciences #PharmaTrends #2028Outlook #HealthcareMarket #MarketAnalysis #ScientificResearch #PeptideTechnology #IndustryTrends #FutureHealthcare #MedicalInnovation #BiomedicalResearch #PeptideIndustry #MarketInsights #GlobalMarket #HealthcareTrends #ResearchAndDevelopment #PeptideScience #EmergingMarkets #BiotechTrends #PharmaMarket #HealthcareSector #IndustryGrowth #Biopharmaceuticals #MedicalAdvancements #PeptideDevelopment #MarketDynamics #HealthTech
Peptide Synthesis Market - Know More About Emerging Trends
marketsandmarkets.com
To view or add a comment, sign in
-
Peptide Synthesis Market worth $859 million by 2028 Download PDF Brochure@ https://lnkd.in/dqJVqwZv The global peptide synthesis market in terms of revenue was estimated to be worth $601 million in 2023 and is poised to reach $859 million by 2028, growing at a CAGR of 7.4% from 2023 to 2028. --> Companies Profiled in this report: Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Kaneka Corporation (Japan), GenScript Biotech Corporation (China), and Bachem Holding AG (Switzerland) --> The Other Companies Operating in This Industry Globally: Peptidream PolyPeptide Group CEM Corporation Syngene International Limited CSBio AnaSpec AAPPTec Biotage GL Biochem (Shanghai) Ltd. LifeTein.com BioSynthesis.io Pepceuticals Phoenix Pharmaceuticals, Inc. 21st Century Biochemicals JPT Peptide Technologies P3 BioSystems Enzo Life Sciences, Inc. Zymo Research Corp Advanced ChemTech Repligen Corporation PurePeptides.io Iris Biotech GmbH Eurogentec ProteoGenix ProImmune Peptide Institute AmbioPharm - A Global Peptide CDMO
[PDF] Peptide Synthesis Market - Emerging Trends & Global Future Forecasts
marketsandmarkets.com
To view or add a comment, sign in
-
Peptide Synthesis Market worth $859 million by 2028 Download PDF Brochure@ https://lnkd.in/d5RXduzz The report "Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028", is projected to USD 859 million by 2028 from USD 601 million in 2023, at a CAGR of 7.4% between 2023 and 2028. Companies Profiled in This Report: Thermo Fisher Scientific Merck KGaA, Darmstadt, Germany KANEKA CORPORATION GenScript Bachem among others.....! Other Companies Operating in This Industry, Globally: AstraZeneca Peptide Synthesis & Amino Acids - Omizzur Synlogic Pharmacosmos Zymeworks Inc. Adesis, Inc. Peptide Sciences Hybrigenics Abzena JPT Peptide Technologies Senn Chemicals AG Peptron, Inc. ProteoGenix Roche Bio Synthesis
Peptide Synthesis Market
marketsandmarkets.com
To view or add a comment, sign in
-
Great to see our recent Perspective on covalent warheads in #MedChem and #ChemicalBiology highlighted again on Linkedin
Interesting #JMedChem perspective article on Emerging and Re-emerging #Warheads for Targeted #CovalentInhibitors in #medicinalchemistry & #drugdiscovery.
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
pubs.acs.org
To view or add a comment, sign in
-
Did you know that Solvias' renowned analytical expertise is also available for peptides? With over 20 peptide projects under our belt, we leverage our extensive experience and state-of-the-art technology to ensure your development stays on schedule and within budget. Learn more about our comprehensive services for peptides on our dedicated page: 🔗 Check it out: https://lnkd.in/eSze2-8p #Solvias #PeptideTesting #PharmaceuticalResearch #AnalyticalExcellence #QualityControl
To view or add a comment, sign in
-
-
Understanding the stability of your cannabinoids standards is essential to generating accurate data. In this 30-day study, we evaluated the stability of 16 acidic and neutral cannabinoids in blended working standards that were prepared in different diluents and stored across a range of laboratory conditions: https://lnkd.in/enB9Udfq
To view or add a comment, sign in
-